Diclofenac Sodium 1.5% Solution
Product Images NDC 71205-640

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium 1.5% (NDC 71205-640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-640-15 (267406 Diclofenac Sodium 150ml Carton Final Copy 2)

71205-640-15 (267406 Diclofenac Sodium 150ml Carton Final Copy 2)
Diclofenac Sodium 1.5% w/w is a topical solution for external use only. Each mL contains 16.05mg of diclofenac sodium USP. It is available in 5fl oz (150mL) units and is RX only. The product is produced by Sola Pharmaceuticals LLC and was relabeled by Proficient Rx LP. The lot number for this product is 00000 and is supplied with a medication guide which is to be provided to each patient. It is recommended to store the product at 25°C (77°F) until its expiration date. Product ID is SD064015 and TIN is 0037120564015.*
FDA Label Image

Eff 2 (Efficacy 2 Copy)

Eff 2 (Efficacy 2 Copy)
The text is a list of variables related to efficacy including the WOMAC pain score, WOMAC physical function score, PGA, and some measurement of vehicle formulation. The information is likely part of a scientific study or medical report.*
FDA Label Image

Efficacy (Efficacy Variable Copy)

Efficacy (Efficacy Variable Copy)
This appears to be a table or chart showing the mean baseline score and mean change in efficacy variables after 12 weeks of treatment with Diclofenac Sodium and two topical formulations, Placebo and Vehicle. The efficacy variables listed are the WOMAC pain score and WOMAC physical function score. The percentage of DVISO and DMSO in the placebo and vehicle formulations are also shown.*
FDA Label Image

Figure A (Figure A Copy)

FDA Label Image

Figure B (Figure B C Copy)

FDA Label Image

Molecule (Molecule Copy)

FDA Label Image

Pharmacokinetic (Pharmacokinetic Parameters Copy)

Pharmacokinetic (Pharmacokinetic Parameters Copy)
Pharmacokinetic parameters for Disifenac Sodium were measured in both normal adults and adolescents over a period of 7 days with single and multiple doses. The results include measurements of plasma concentrations, clearance rate, and volume of distribution.*
FDA Label Image

Treatment (Treatment Group Copy)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.